Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin by Schmidt, Nadine et al.
JCB: Article
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 195 No. 7  1171–1184
www.jcb.org/cgi/doi/10.1083/jcb.201107083 JCB 1171
N. Schmidt, M. Akaaboune, and N. Gajendran contributed equally to this paper.
Correspondence to Mohammed Akaaboune: makaabou@umich.edu; or Hans 
Rudolf Brenner: Hans-Rudolf.Brenner@unibas.ch
Abbreviations used in this paper: AChE, acetylcholine esterase; AChR, acetyl-
choline receptor; -BTX, alpha-bungarotoxin; -DB, alpha-dystrobrevin; NMJ, 
neuromuscular junction; NRG, neuregulin.
Introduction
Neuregulins and their effectors, the ErbBs, are major factors 
involved  in  the  function  of  central  and  peripheral  synapses. 
Their mode of action has remained elusive, however. At the neu-
romuscular junction (NMJ) NRG1 from motor neurons activat-
ing ErbB receptors in muscle has been proposed to control 
achr subunit gene expression from subsynaptic muscle nuclei 
(Schaeffer et al., 2001). However, mice in which NRG/ErbB 
signaling to muscle is prevented by abolishment of erbb2 and 
erbb4 genes selectively in muscle nonetheless express synaptic 
achr genes at almost normal levels (Escher et al., 2005). Thus, 
the function of NRG1/ErbB signaling at the NMJ has remained 
unknown to this date. The present work is aimed at elucidating 
this function.
At the mature NMJ, the density of acetylcholine receptors 
(AChRs) is determined by an equilibrium between the insertion 
of  receptors  into,  and  their  removal  from,  the  postsynaptic 
membrane. Like synaptic receptors in the central nervous sys-
tem,  AChRs  can  shuttle  between  synaptic  and  nonsynaptic 
zones (Akaaboune et al., 2002). Once internalized, the AChRs 
are not simply degraded. A significant number of internalized 
receptors are recycled back into the postsynaptic membrane in 
a manner that depends on muscle activity (Bruneau et al., 2005a; 
2009, Bruneau and Akaaboune, 2006).
The  maturation  and  maintenance  of  the  postsynaptic 
membrane at the NMJ are tightly controlled by the dystrophin 
glycoprotein  complex.  For  example,  synapses  deficient  in   
-dystrobrevins (-DB), a component of the postsynaptic appara-
tus involved in the anchoring of the AChRs in the synaptic 
membrane, have an abnormal pattern of AChR distribution, a 
reduced level of AChRs, and a lower stability of receptors in the 
postsynaptic membrane (Grady et al., 2000, 2003). Rescue of 
the synaptic phenotype in -db
/ muscle fibers required expres-
sion of phosphorylatable wild-type -dystrobrevin1 (-DB1), 
N
euregulin (NRG)/ErbB signaling is involved in 
numerous developmental processes in the ner-
vous system, including synapse formation and 
function in the central nervous system. Although inten-
sively investigated, its role at the neuromuscular syn-
apse has remained elusive. Here, we demonstrate that 
loss of neuromuscular NRG/ErbB signaling destabilized 
anchoring of acetylcholine receptors (AChRs) in the post-
synaptic  muscle  membrane  and  that  this  effect  was 
caused by dephosphorylation of -dystrobrevin1, a com-
ponent of the postsynaptic scaffold. Specifically, in mice 
in which NRG signaling to muscle was genetically or 
pharmacologically abolished, postsynaptic AChRs moved 
rapidly from the synaptic to the perisynaptic membrane, 
and  the  subsynaptic  scaffold  that  anchors  the  AChRs 
was impaired. These defects combined compromised syn-
aptic  transmission.  We  further  show  that  blockade  of 
NRG/ErbB signaling abolished tyrosine phosphoryla-
tion of -dystrobrevin1, which reduced the stability of re-
ceptors  in  agrin-induced  AChR  clusters  in  cultured 
myotubes. Our data indicate that NRG/ErbB signaling 
maintains high efficacy of synaptic transmission by sta-
bilizing the postsynaptic apparatus via phosphorylation 
of -dystrobrevin1.
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Genetic and pharmacological abolishment of   
ErbBs accelerates the migration of recycled   
receptors to the perisynaptic membrane
AChRs  move  between  junctional  and  perijunctional  regions 
(Akaaboune et al., 1999, 2002), and receptors lost from the 
synaptic to the perisynaptic membrane condense into small ac-
cumulations (called AChR puncta below) that are thought to be 
internalized (Akaaboune et al., 1999). Having shown that the 
lack of NRG/ErbB signaling promotes selectively the removal 
of recycled AChRs (Fig. 1 b) from the synapse, we next exam-
ined whether the migration of synaptic AChRs to the perisynap-
tic  membrane  and/or  their  internalization  were  altered  in 
mutant mice. By comparing AChR puncta doubly stained with   
-BTX–Alexa 594 and with Mab35 in unpermeabilized mus-
cle, changes in the rates of internalization of AChR puncta ver-
sus changes in AChR migration can be resolved (Fig. S2). Using 
this approach, we thus compared the number of puncta contain-
ing preexisting and recycled AChRs in the perisynaptic surface 
membrane  of  erbb2/4
/  and  wild-type  muscles.  Receptors 
were stained as indicated in Materials and methods, and 2 d later, 
surface receptors were immunostained with (Mab35)/Alexa 488 
(Fig. 2 a).
Counts of the number of puncta in the perisynaptic mem-
brane containing red (recycled) and blue (preexisting) AChRs 
showed  that  the  number  of  puncta  containing  preexisting 
AChRs was no different in mutant and in wild-type synapses 
(Fig. 2 b). In contrast, the number of puncta containing recycled 
AChRs in erbb2/4
/ muscle was about twice that in wild-
type muscle (Fig. 2 b). This is consistent with the increased 
loss of recycled AChRs from the synaptic membrane (Fig. 1 b). 
Co-staining surface AChRs with anti-AChR antibody (green) 
showed that for recycled AChRs, the number of both surface 
and internalized AChR puncta in mutant mice was about twice 
that in the wild-type mice (Fig. 2 b). Thus, although there 
were twice as many puncta in the perijunctional zone of mu-
tant mice, the fraction of those puncta that were internalized 
was essentially the same as in the wild-type mice (2.00 vs. 
2.2). This indicates that NRG/ErbB signaling controls the 
migration of AChRs from synaptic to perisynaptic sites; in 
contrast, their internalization from the perisynaptic zone is 
not affected.
With erbb2
/ synapses (Leu et al., 2003) showing simi-
lar declines in synaptic AChR densities and miniature endplate 
current amplitudes as erbb2/4
/ synapses (Escher et al., 2005), 
we examined erbb2
/ synapses for increases in AChR puncta 
and  in  perisynaptic  AChR  streaks,  another  characteristic  of 
erbb2/4
/ NMJs. Indeed, both of these characteristics as well 
as the incidence of perforations in synaptic AChR clusters were 
increased (see following paragraph), suggesting that the synap-
tic changes observed were primarily, if not entirely, due to erbb2 
deletion (unpublished data).
Finally, as in erbb2/4
/ muscles, both the development 
of streaks of AChRs as well as enhanced migration of AChRs to 
the perisynaptic membrane was also seen in wild-type muscles 
that had been treated for 8 h with tyrphostins AG1478 and 
AG879 (10 µM), which are blockers of ErbB4 and ErbB2, re-
spectively (Fig. S3; Fukazawa et al., 2003; Woo et al., 2007). 
which serves as a substrate for tyrosine kinases (Grady et al., 
2003). However, the signaling pathway inducing phosphoryla-
tion of -DB1 remains unknown.
Here we demonstrate a new role of NRG1/ErbB signaling in 
the maintenance of the NMJ postsynaptic membrane. In particular, 
we found that NRG1/ErbB signaling is critical for the stability of 
the AChRs, selectively of recycled AChRs, in the synaptic mem-
brane and for the structural integrity of the postsynaptic apparatus. 
Structural changes in the postsynaptic apparatus of erbb2/4
/ 
synapses are coupled to reduced effectiveness of neuromuscular 
impulse transmission. Finally, we demonstrate that -DB1 is a 
substrate for ErbB receptor tyrosine kinases, and that dephos-
phorylation of -DB1 by ErbB deletion loosens AChRs in 
agrin-induced AChR clusters. Our experiments combined there-
fore indicate that NRG/ErbB, by phosphorylation of -DB1, stabi-
lizes the postsynaptic apparatus and, thus, contributes to anchoring 
the AChRs in the synaptic membrane.
Results
Deletion of NRG/ErbB accelerates the 
removal of AChRs from NMJs in vivo
In our previous work we showed that neuromuscular NRG/ErbB 
signaling is not necessary for synapse-specific expression of genes 
by subsynaptic nuclei of the mouse NMJ (Fig. S1; Escher   
et al., 2005).
To examine whether ErbB-mediated signaling is, instead, 
involved in regulating the stability of postsynaptic AChRs at 
the NMJ, the sternomastoid muscle of wild-type and erbb2/4
/ 
mice (Escher et al., 2005) was labeled to saturation in vivo with 
fluorescent -bungarotoxin (-BTX)–Alexa 594, and the decline 
in fluorescence of labeled AChRs was monitored over time. In 
erbb2/4
/ NMJs the residual fluorescence normalized to that at 
the time of labeling was significantly lower than in wild-type 
synapses (Fig. 1 a; 30% vs. 60% at 72 h). This indicates that 
the lack of ErbB-mediated signaling increases the rate of synap-
tic AChR removal.
A significant fraction of internalized AChRs recycle back 
into the postsynaptic membrane and intermingle with preexist-
ing (i.e., not yet internalized) AChRs (Bruneau et al., 2005a; 
Bruneau and Akaaboune, 2006). We next examined if these two 
receptor pools are differentially affected by the loss of NRG/
ErbB signaling. Therefore, the different AChR pools were 
fluorescently labeled as described in the Materials and methods 
section.  Doubly  labeled  synapses  (preexisting  and  recycled 
AChRs) on the surface of the muscle were immediately imaged 
and then reimaged 24, 48, and 72 h later. To exclude an effect 
of AChR labeling on electrical muscle activity and, thus, on AChR 
cycling, muscles were labeled with a low dose of -BTX–biotin, 
leaving impulse transmission largely normal (Akaaboune et al., 
1999).  We  found  that  fluorescence  of  recycled  receptors  in 
erbb2/4
/ muscles was lost more rapidly than in wild-type 
muscles (Fig. 1 b). In contrast, the loss of preexisting receptors 
in erbb2/4
/ muscles was nearly the same as that at wild-type 
synapses (Fig. 1 b). These results show that NRG/ErbB signal-
ing is involved in controlling the stability of recycled, but not of 
nonrecycled AChRs in the postsynaptic muscle.1173 NRG/ErbB function at the neuromuscular junction • Schmidt et al.
To see whether AChR holes developed from focal recep-
tor loss from the synaptic cluster, we double labeled adult 
synapses (2 mo) for AChRs (-BTX–Alexa 488) and acetyl-
choline esterase (AChE), using the snake toxin fasciculin2 
coupled to Alexa 594 (Peng et al., 1999; Krejci et al., 2006; 
Martinez-Pena y Valenzuela and Akaaboune, 2007). Fascic-
ulin2 fluorescence was present at the sites from which AChR 
fluorescence was missing. In addition, we observed that en-
tire branches of the NMJ were eliminated in mutant muscle 
(Fig. 3, d and e).
To examine whether the local loss of AChRs might re-
sult from local withdrawal of the nerve terminal, we labeled 
erbb2/4
/ synapses with antibodies to the presynaptic markers 
neurofilament and synaptophysin and with -BTX–Alexa 594 
to stain AChRs. Receptor holes were covered by presynaptic 
terminal branches (Fig. 3 f), suggesting that receptor holes are 
The  similarity  of  effects  upon  pharmacological  and  genetic 
ErbB  deletions  suggests  that  the  tyrphostins  used  acted  by 
blockade of ErbBs.
Lack of ErbB receptors causes structural 
damage to NMJs
High resolution confocal microscopy revealed that mutant mice 
often have small areas within the synaptic AChR cluster that are 
devoid of receptors, giving the cluster a perforated appearance 
(Fig. 3 b). About 45% of mutant synapses showed AChR cluster 
perforations between 17–21 d after birth, which is higher than 
in wild-type muscles (10%). The incidence of formation of 
holes increased with age. By 1 yr nearly 100% of mutant syn-
apses had at least one AChR hole, whereas less than 60% of control 
synapses were affected (Fig. 3 c). These results indicate that loss 
of NRG/ErbB signaling accelerates postsynaptic fragmentation.
Figure 1.  Deletion of NRG/ErbB signaling increases removal of recycled receptor from the postsynaptic membrane. (a) The sternomastoid muscle of 
erbb2/4
/ and wild-type mice was labeled with a saturating dose of -BTX–Alexa 594, and superficial synapses were immediately imaged at time 0 
and reimaged 1, 2, and 3 d later. The total fluorescence intensity of each AChR cluster was normalized to 100% at initial imaging. Examples of NMJs 
shown in pseudocolor provide a linear representation of the density of AChRs at the times indicated (top). Graph summarizing the removal of AChRs in 
wild-type and erbb2/4
/ synapses over the indicated time (mean percentage of fluorescence intensity ± SEM; n = 14–30 synapses from 3 animals [2 for 
erbb2/4
/ at 24 h] for each data point). Note that AChRs are removed significantly faster from erbb2/4
/ than from wild-type synapses. (b) Recycled 
and nonrecycled (preexisting) AChRs were fluorescently labeled with nonblocking doses of -BTX–biotin (see Materials and methods). Doubly labeled 
synapses were imaged immediately and reimaged 24 and 48 h later. Data give mean percentage (±SEM) of residual fluorescence intensity relative to that 
at t = 0. Graph summarizing the results obtained from 4–18 synapses from three animals for each data point (bottom). The removal of recycled but not of 
preexisting AChRs is selectively increased in erbb2/4
/ mutant synapses.JCB • VOLUME 195 • NUMBER 7 • 2011   1174
components of the postsynaptic apparatus were lost from sites 
from which AChRs had disappeared. Indeed, immunoreactivity 
against MuSK, utrophin, and -actin (Fig. 4 a), as well as rapsyn, 
sodium channel (NaCh), and -dystroglycan (not depicted), was 
missing from sites where AChRs had disappeared. This result indi-
cates that ErbB receptors are important not only for AChR stability, 
but also for the maintenance of postsynaptic scaffold proteins.
Additionally,  we  found  that  both  rapsyn  and  utrophin 
were colocalized with increased number of perisynaptic AChR 
not due to localized withdrawal of the nerve due to a presynaptic 
defect resulting from the lack of ErbB-dependent back-signaling 
onto the motor neurons (Bao et al., 2003). Thus, the modified 
distribution of AChRs is a direct consequence of the loss of NRG/
ErbB signaling to the subsynaptic membrane.
AChRs are an integral part of the synaptic scaffold to which 
they are anchored. Thus, the focal loss of AChRs from the synaptic 
membrane  may  locally  destabilize  the  postsynaptic  apparatus 
(Bruneau et al., 2008). We therefore examined whether other 
Figure  2.  Deletion  of  NRG/ErbB  signaling  in-
creases AChR puncta containing recycled but not 
preexisting AChRs in the perisynaptic membrane. 
(a) Labeling method for assessing the accumula-
tion of AChRs in the perisynaptic membrane. 2 d 
after labeling recycled receptor, surface receptors 
were immunostained with the anti-AChR antibody 
Mab35 and Alexa 488 without permeabilization. 
Given are examples of high resolution confocal 
images  of  wild-type  and  erbb2/4
/  NMJs.   
Arrows mark puncta containing preexisting receptors 
(blue) and/or recycled (red) receptors localized 
in  the  perisynaptic  membrane  as  suggested  by 
costaining with nonpermeabilized AChR antibody 
Mab35 (green). Note the higher (twofold) accu-
mulation  of  surface  puncta  containing  recycled 
but not preexisting AChRs in erbb2/4
/ NMJs 
than in the wild type. Bars, 5 µm. (b) Graphs sum-
marizing the quantification of fluorescent data as 
illustrated  in  panel  a.  Surface  and  internalized 
AChR puncta are increased by similar proportions 
in erbb2/4-deficient (2.00 ± 0.26-fold for surface 
and 2.2 ± 0.37-fold for internalized puncta; n = 
29–30 synapses from three mutant and three wild-
type animals) relative to wild-type muscle, indicat-
ing  unchanged  internalization  rates.  Therefore, 
the loss of NRG/ErbB signaling accelerates spe-
cifically the migration of recycled AChRs from the 
synaptic sites. (c and d) Endplates in erbb2/4
/ 
muscle  acutely  stained  with  -BTX–Alexa  594 
show  increased  numbers  of  perisynaptic  AChR 
puncta  (32  NMJs  from  three  wild-type  and  25 
NMJs from three erbb2/4
/ mice; **, P < 0.01) 
and  formation  of  AChR  streaks  extending  from 
synaptic into perisynaptic membrane (244 NMJs 
from  three  wild-type  and  259  NMJs  from  three 
erbb2/4
/mice; **, P < 0.01). Bars, 5 µm.1175 NRG/ErbB function at the neuromuscular junction • Schmidt et al.
Although synaptic vesicles had a normal distribution in the 
presynaptic nerve terminals of both mutants and controls, the 
structure of the postsynaptic apparatus was abnormal in the mu-
tants, with a scarcity of synaptic folds in the synaptic membrane 
(Fig. 4 b). Consistently, high resolution confocal microscopy of 
the AChR-rich interfold ridges suggested the scarcity of folds in 
mutant NMJs: Within an endplate a loss AChR-positive ridges 
puncta characteristic of mutant synapses (Fig. S4), mirroring 
the focal loss of the postsynaptic apparatus described above. 
These data suggest that the lack of NRG/ErbB signaling increases 
the loss of postsynaptic scaffold proteins from the synaptic sites 
to the perisynaptic region.
Finally, we examined the ultrastructure of the postsynaptic 
apparatus in NMJs of erbB2/4
/ mice, using electron microscopy. 
Figure 3.  Structural changes in erbb2/4
/ NMJs. Synaptic AChR clusters develop perforations, and synaptic branches are lost. (a and b) Confocal 
images of adult wild-type (top) and erbb2/4
/ NMJs (a, center; b, center left) doubly labeled with fasciculin2–Alexa 594 (for AChE, red) and -BTX–Alexa 
488 (AChRs, green). Bars: (a) 10 µm; (b) 5 µm. Overlap of green and red is complete in wild-type but not in erbb2/4
/ NMJs, where AChE staining is 
observed where AChRs are missing (perforations). This indicates that perforations form in cluster regions previously occupied by AChRs. (c) Graph illustrat-
ing increased percentage of synapses with perforated clusters in 17–21-d, 2-mo-, and >12-mo-old erbb2/4
/ muscles compared with wild-type muscles 
of the same age (n > 100 synapses from at least three wild-type and three mutant mice for each age; **, P < 0.01). (d) High resolution images of a lost 
NMJ branch indicated by the presence of AChE staining without AChR staining. Micrograph from wild-type NMJ is given in panel a. Bar, 5 µm. (e) Graph 
summarizing the enhanced percentage of NMJs with missing branches in erbb2/4
/ muscle (n = 89 synapses from three mutant muscles and 63 synapses 
from three wild-type muscles at 2 mo; **, P < 0.01). (f) Presynaptic terminal branches remain at postsynaptic AChR cluster perforations, indicating that the 
latter are not due to focal withdrawal of the nerve terminal. AChRs (red) stained with -BTX–Alexa 594, presynaptic terminal (green) stained with antibodies 
to synaptophysin and neurofilament. Bars, 5 µm.JCB • VOLUME 195 • NUMBER 7 • 2011   1176
d-tubocurarine (d-TC) to wild-type muscles to cause a partial 
block of AChRs. At a concentration of 340 nM there was a just-
detectable reduction in the tetanic contraction in response to 
nerve, but not to muscle stimulation. When the same d-TC 
concentration (340 nM) was applied to erbb2/4
/ muscles (five 
mice), profound impairment of nerve-induced tetanic contrac-
tions in mutant muscles was induced (Fig. 5). These results 
indicate that erbb deletion lowers the safety factor of synap-
tic transmission.
ErbBs stabilize agrin-induced AChR 
clusters in cultured myotubes by 
phosphorylation of -dystrobrevin1
Next, we examined a potential mechanism by which ErbB 
signaling might control the stability of the postsynaptic mem-
brane. ErbB receptors have tyrosine kinase activity, and tyro-
sine phosphorylation is critical for synaptic plasticity. In mice 
deficient in -dystrobrevin (-DB), the phenotype of endplates 
(Banks et al., 2003) resembles in some aspect that in erbb2/4
/ 
mutants; conspicuously, the neuromuscular phenotype of -db
/ 
muscle can only be rescued by exogenous -DB1 containing 
did not evenly affect all subclusters, but was preferentially near 
areas of cluster perforations (Fig. 4 b). Together, these experi-
ments suggest that ErbB deficiency structurally destabilizes the 
subsynaptic membrane.
Lack of ErbB receptors compromises 
impulse transmission
The abnormalities of ultrastructure and molecular organization 
described in the previous section in erbb2/4
/ muscle involve 
features of the NMJ that are known to affect the efficacy of 
neuromuscular transmission (Slater, 2008). To assess that effi-
cacy, we compared isometric tetanic tension generated by mu-
tant and wild-type soleus muscles in response to 50- and 120-Hz 
trains of stimuli to the soleus nerve. The tension in response to 
stimulating the nerve, relative to that in response to stimulating 
the muscle directly, was taken as a measure of the efficacy of 
neuromuscular impulse transmission (Witzemann et al., 1996).
In  physiological  Krebs  solution,  tensions  to  nerve  and 
muscle stimulations were identical, both in erbb2/4
/ and in 
age-matched wild-type muscles (Fig. 5). To look more critically 
at the safety factor for neuromuscular transmission, we added 
Figure 4.  MuSK and components of the subsynaptic apparatus are lost from AChR cluster perforations of erbb2/4
/ synapses. Junctional folds are locally 
lost. (a) Sternomastoid muscle from 2-mo-old erbb2/4
/ mice were fixed and stained with -BTX–Alexa 594 and antibodies to the indicated proteins. Note 
that all tested proteins are concentrated at synaptic sites except in perforations from where receptors have been lost. A’: MuSK, B’: utrophin, C’: -actin. 
Bars, 5 µm. (b) Electron micrographs of control and erbb2/4
/ muscle (top and middle panel). Nerve terminal endings appeared normal in both mutant 
and wild type, but in the former synaptic folds were scarce or even lacking (bracket). The mean numbers of fold openings per synaptic contact length 
were 0.86 ± 0.1 (n = 19) in erbb2/4-deficient and 1.25 ± 0.07 (n = 18) in wild-type muscles. Bottom: high resolution confocal images of wild-type and 
erbb
/ NMJs labeled with -BTX–Alexa 594. Note that the net loss of folded structure of the postsynaptic membrane primarily in the vicinity of cluster 
perforations (arrowhead).1177 NRG/ErbB function at the neuromuscular junction • Schmidt et al.
myotubes (Fig. 6 c). Note that in cultures that were not treated 
with neutralizing antibody, AChR cluster size was not affected 
by the addition of exogenous NRG1 (not depicted), indicating 
that secreted NRG1 activity was sufficient to fully saturate 
AChR stability (see also Fig. 7). These data demonstrate on the 
functional level that NRG/ErbB stabilizes agrin-induced AChR 
clusters via a process involving phosphorylation of -DB1.
To test whether NRG/ErbB phosphorylates tyrosine resi-
dues in -DB1, C2C12 and primary wild-type myotubes were 
cultured on a substrate of agrin-impregnated laminin (Lacazette 
et al., 2003) to induce large areas of subsynaptic apparatus. 
Given that both pharmacological and genetic abolishment of 
ErbB function enhance AChR migration at endplates in vivo 
(Fig. 2 and Fig. S3), cultured myotubes (C2C12 and primary 
wild type) were incubated with 5 µM ErbB blockers or 5 nM 
NRG1 either in the presence or absence of peroxivanadate 
(inhibitor  of  phosphatases),  and  the  phosphorylation  of   
-DB1 was analyzed. As -DB1 is complexed with utrophin 
and syntrophin, lysates were immunoprecipitated with an anti-
body (SYN1351) recognizing - and -syntrophins (Froehner 
et al., 1987). Precipitates were denatured and blotted with 
intact tyrosine phosphorylation sites (Grady et al., 2003). There-
fore we sought to test whether NRG/ErbB signaling stabilizes 
agrin-induced AChR clusters in cultured myotubes via the 
phosphorylation of -DB1.
If the stability of agrin-induced AChR clusters is NRG/
ErbB-dependent in wild-type muscle and if this process is 
mediated by phosphorylation of -DB1, the stability of AChRs 
should not be affected by the presence of NRG in -db
/ myo-
tubes. To test this prediction, cultures were first treated with a 
function-blocking antibody (Meier et al., 1998) to neutralize 
NRG1 activity secreted by the myotubes. Exogenous NRG1 
was then added to test cultures (Fig. 6 a). Indeed, in wild-type 
myotubes NRG1 neutralization reduced the size of agrin-
induced AChR clusters compared with myotubes exposed to 
NRG1;  in  contrast,  AChR  clusters  in  -db
/  myotubes 
(which  have  reduced  AChR  cluster  size;  Pawlikowski  and 
Maimone, 2009) were not affected by NRG1 neutralization or 
addition (Fig. 6 b). However, NRG dependence of AChR cluster 
stability could be rescued when a wild-type, i.e., phosphorylat-
able, but not when a mutant, i.e., nonphosphorylatable, con-
struct of -DB1 (Grady et al., 2003) was expressed in -db
/ 
Figure 5.  Impulse transmission at synapses in erbb2/4
/ 
muscle is impaired. (a) Isometric force of wild-type soleus 
muscle in response to a 120-Hz stimulus train to the so-
leus nerve. From left to right: in normal saline, in saline 
containing 340 nM d-tubocurarine-Cl (d-TC), after 30 min 
wash-out. (b) Isometric force of an erbb2/4
/ muscle   
(same protocol as in panel a). Note depression of contrac-
tion by 340 nM d-tubucurarine and complete recovery   
of contraction after wash-out. (c) Force developed by the 
same muscle as in b, but in response to muscle stimula-
tion.  Note  that  contraction  is  not  affected  by  340  nM 
d-tubocurarine-Cl.  (d)  Example  of  evaluation  of  tension 
recordings as illustrated in a and b. Fmax, maximum iso-
metric force developed during nerve stimulus train; Fe, 
isometric force at end of train; subscripts c, d-TC refer to 
forces developed in control and in d-TC–containing solu-
tions, respectively. (e) Graph summarizing depression of 
responses in wild-type and erbb-deficient muscle treated 
with 340 nM d-TC analyzed as illustrated in d. Note the 
impairment of neuromuscular transmission during tetanic 
nerve stimulation in erbb2/4
/ muscles (n = 4 wild-type 
and 5 erbb2/4
/ muscles).JCB • VOLUME 195 • NUMBER 7 • 2011   1178
alone (Fig. S5). In C2C12 myotubes, -DB1 phosphorylation 
and its blockade by ErbB inhibitors could also be resolved with-
out peroxivanadate pretreatment. However, the level of tyrosine-
phosphorylated -DB1 was then substantially lower (Fig. 7 a, 
legend), indicating that inhibition of dephosphorylation allows 
accumulation of phosphorylation.
Abolishment of -DB1 phosphorylation by ErbB blockers 
was  also  observed  when  -DB1  was  pulled  down  directly 
from C2C12 myotubes (Fig. 7 b). In contrast, -syntrophin 
phosphorylation was not affected by ErbB blockade, at least 
on the time scale investigated (Fig. 7 a). Moreover, the abun-
dance of neither -syntrophin nor utrophin in the precipitate 
anti-phosphotyrosine (4G10), anti–-DB1, and anti–-syntrophin 
antibodies (Adams et al., 2000).
Fig. 7 a shows that there was substantial phosphorylation 
of -DB1 in untreated cells, and added NRG1 did not further 
increase phosphorylated -DB1 beyond this basal level, pre-
sumably due to autocrine ErbB activation (Meier et al., 1998) 
and consistent with full AChR stabilization by secreted NRG1 
in the absence of neutralizing antibody (see Fig. 6 b and text 
above). In contrast, pharmacological blockade of NRG/ErbB 
signaling  substantially  reduced  phosphorylation  of  -DB1 
both in primary and C2C12 myotubes. Similar results were ob-
tained when myotubes were incubated with 5 µM ErbB2 blocker 
Figure 6.  The stability of agrin-induced AChR clusters in cultured myotubes depends on the presence of NRG and on phosphorylation of -dystrobrevin1. 
Myoblasts were seeded on laminin substrates containing focal agrin deposited by agrin-transfected COS-1 cells, and differentiated. AChR clusters were 
induced where myotubes contacted agrin deposits. (a) Experimental protocol. Myotubes (wild type, transfected wild type, or -db
/ mutant) were prein-
cubated for 12 h in the presence of 30 µg/ml anti-NRG1 antibody to neutralize autocrine NRG activity and then stained with -BTX–Alexa 594 (red). 
In one set (labeled +NRG1), antibody was then removed and replaced by 5 nM NRG1; in the other set (labeled NRG1), removed antibody was 
replaced with a fresh dose of antibody. Both sets of cultures were fixed after 6 h. (b) NRG1 stabilizes AChR clusters only in wild-type, but not in -db
/ 
mutant myotubes. Left: Examples of agrin-induced AChR clusters (marked by arrows) in wild-type and -db
/ mutant myotubes maintained in the presence 
and absence of NRG1, respectively. Both sets of cultures were fixed after 6 h. Bar, 20 µm. Right: Quantification of AChR cluster area (n = 64–86 clusters 
analyzed per group; data from three parallel cultures). (c) NRG1 stabilizes agrin-induced AChR clusters in -db
/ myotubes only when expressing wild-
type -DB1, but not when expressing nonphosphorylatable -DB1. Agrin-induced AChR clusters in -db
/ mutant myotubes transfected to express GFP-
tagged wild type (GFP--DB1) or nonphosphorylatable (GFP--DB1-P3
-) -dystrobrevin1 (Grady et al., 2003) are compared. Left: Confocal images shows 
“rescued” agrin-induced AChR cluster (red) in GFP-DB1–expressing myotubes (green). Elevated GFP-DB1 was colocalized with AChR clusters. Bar, 5 µm. 
Right: Quantification of AChR cluster area (n = 30–40 clusters analyzed per group). Note the inability of exogenous NRG1 to stabilize AChR clusters in 
the absence of phosphorylatable -dystrobrevin1.1179 NRG/ErbB function at the neuromuscular junction • Schmidt et al.
-DB1 phosphorylation (Fig. S5). Based on this result, i.e., that 
phosphorylation of -DB1 was not due to EGFR signaling, we 
used both ErbB4 and ErbB2 blockers to completely eliminate 
all NRG1 signaling, i.e., also that through ErbB4. Second, we 
assayed phosphorylation of -DB1 in -syntrophin pull-downs 
from myotubes derived from immortalized erbb2/4
/ myoblasts. 
Consistent with the data described above, phosphorylation 
was affected, demonstrating that the stability of the complex 
by itself is independent of the phosphorylation/dephosphory-
lation mechanism.
To exclude the possibility that phosphorylation of -DB1 
was due to ErbB1 signaling, we used the ErbB2 blocker AG879 
alone (5 µM, which at this concentration does not block EGFR 
signaling; Levitzki and Gazit, 1995) and found that it blocked 
Figure  7.  Blockade  of  NRG/ErbB  signaling 
abolishes phosphorylation of -dystrobrevin1 
and  destabilizes  agrin-induced  AChR  clus-
ters. (a) ErbB blockers AG879 and AG1478   
(5 µM each) abolish phosphorylation of -DB1. 
-DB1 was pulled down with an anti-syntrophin 
antibody  from  myotubes  grown  on  laminin 
coated  with  neural  agrin.  After  blotting, 
tyrosine  phosphorylation  was  detected  with 
the anti-PY antibody (4G10) and precipitated 
proteins  with  the  respective  antibodies.  Syn-
trophin blots served as loading controls. Phos-
phorylation of -DB1 in absence of exogenous 
NRG1 was due to autocrine action of NRG1 
secreted  from  the  myotubes  (Jones  et  al., 
1999), preventing further phosphorylation by 
exogenous NRG1. For vanadate-pretreated 
samples  in  the  4G10  blots  the  exposure   
after ECL development was 10 times shorter 
than for nontreated samples, reflecting a very 
rapid  dephosphorylation  process.  (b)  Same 
experiment as in panel a, except that IP was 
with the anti–-DB1 antibody used in panel a 
for  protein  detection.  Phosphorylation  of  the 
75-kD isoform of -DB1, but not of other pro-
teins pulled down by anti–-DB1 antibody, is 
blocked by pharmacological ErbB blockade. 
Note that the 75-kD band, when detected with 
-DB1 antibody, appears stronger in intensity, 
as  the  immunoprecipitation  with  the  -DB1 
antibody pulls down not only the -DB1 asso-
ciated with the syntrophin–DG complex (as ob-
served using anti-syntrophin 1351 antibodies) 
but also uncomplexed -DB1. The positions of 
size markers are indicated. (c) Genetic deletion 
of ErbBs abolishes phosphorylation of -DB1 
by NRG1. Same experiment as in panel a, 
except that erbb2/4
/ myotubes were used, 
and  a  larger  section  of  the  blot  is  shown. 
No bands can be resolved at 75 kD in blots 
from ErbB-deficient cells, unlike in the -DB1 
pull-downs  of  C2C12  myotubes  performed 
under similar conditions (b). The clear band 
just below 75 kD cannot be -DB1 because 
it is not observed in IPs with the anti–-DB1 
antibody.  The  positions  of  size  markers  are 
indicated.  (d)  Genetic  abolishment  of  ErbBs 
reduces  the  stability  of  agrin-induced  AChR 
clusters. Left: Example of agrin-induced AChR 
clusters and manual delineation of their edges 
for  estimation  of  cluster  area  after  staining 
with -BTX–Alexa 594. Agrin was deposited 
on laminin substrate as described in Materials 
and methods. Confocal image of cluster post-
stained at 0 h with -BTX–Alexa 488 shows 
only original (red) staining. 6 h later, original 
receptors  (red)  prevail  at  center  and  newly 
inserted  (green)  AChRs  at  cluster  periphery. 
Bars, 10 µm. Right: Quantification of area oc-
cupied by original AChRs stained at 0 h and 
those remaining at 6 h. Note that the decrease 
in  cluster  size  is  more  rapid  in  erbb2/4
/ 
than in wild-type myotubes (n = 60–77 clusters 
analyzed). The positions of size markers (in kD) 
are indicated.JCB • VOLUME 195 • NUMBER 7 • 2011   1180
Discussion
The present experiments show, by deletion of ErbB2 and ErbB4 
receptors, that NRG1/ErbB signaling is essential for the main-
tenance of a normal number of AChRs at the adult NMJ, in 
agreement with a previous report in which NRG/ErbB signaling 
was impaired by deletion of one of the nrg-1 alleles (Sandrock 
et al., 1997). However, synaptic phenotypes in these mutants 
cannot be compared at the quantitative level because in the former, 
neuromuscular NRG1/ErbB signaling was not completely abol-
ished, and as indirect effects, e.g., via Schwann cells, cannot 
be excluded.
The present experiments now show that one mechanism 
by which NRG maintains synaptic AChR numbers is by en-
hancing the stability of their anchoring to the synaptic muscle 
membrane via activation of ErbBs and tyrosine phosphoryla-
tion of -DB1. This is suggested by (i) the destabilization of 
AChRs observed upon pharmacological or genetic abolishment 
of ErbB receptor function at agrin-induced AChR clusters in 
myotubes as well as at adult NMJs in vivo; (ii) the dephosphor-
ylation of -DB1 in cultured myotubes; and (iii) the dependence 
of NRG-induced AChR cluster stabilization on the presence of 
-DB, specifically of phosphorylatable -DB1. These observa-
tions are consistent with previous studies showing that -DB1 is 
a key component of the synaptic DGC that is essential for nor-
mal maturation and stabilization of the postsynaptic membrane 
by providing a molecular link between cytoplasmic F-actin 
and the basal lamina of the muscle fiber (Banks et al., 2003).
Consistent with our findings, the endplates in erbb2/4
/ 
muscles share some similarities with those observed in muscles 
lacking dystroglycan (Jacobson et al., 2001), -syntrophin (Adams 
et al., 2000), utrophin (Deconinck et al., 1997b; Grady et al., 
1997), and -DB1 (Grady et al., 1999), which form the DGC. 
While common to both erbb2/4
/ and -db mutant muscles are 
similar reductions in metabolic AChR half-life and in the num-
ber of synaptic folds, the reductions in AChR density and in the 
density  of  AChR  streaks  are  both  stronger  in  -db  mutants 
(Grady et al., 1997, 2000; Akaaboune et al., 2002; Escher et al., 
2005). The synaptic phenotype in erbb2/4
/ mutant muscle 
would likely be milder than that in -db mutant muscle because 
the lack of -DB1 phosphorylation in erbb2/4
/ mutants may 
impair, but does not abolish, the formation of the syntrophin–
dystrobrevin–utrophin complex; moreover, in -db
/ mutants, 
not only -DB1, but also -DB2 isoforms are deleted, both of 
which contribute in part to the stability of the synaptic mem-
brane in wild-type muscle, independently of whether they can be 
phosphorylated (Grady et al., 2003; Pawlikowski and Maimone, 
2009). Nevertheless, the appearance of AChR holes at P17 (Fig. 3) 
as a consequence of the mere lack of phosphorylation of -DB1 
(as found here) would compare well with the late onset of the NMJ 
phenotype in -db
/ mutants (Grady et al., 2000), where all 
-DB isoforms are ablated.
NRG/ErbB-dependent phosphorylation/dephosphorylation of   
-DB1 is a highly dynamic process. Specifically, 30 min pre-
incubation with peroxivanadate was sufficient to increase the 
level of tyrosine-phosphorylated -DB1 in myotubes sub-
stantially beyond that in untreated cells, a process that could be 
of -DB1 could not be detected, either in the absence or the 
presence of exogenous NRG1 (Fig. 7 c). The result was simi-
lar in pull-downs with anti-DB1 antibody. Thus, abolishment 
of -DB1 phosphorylation was due to ErbB blockade rather than   
to a nonspecific effect of the pharmacological ErbB blockers 
(Fig. 7 c). These experiments combined show that NRG/ErbB sig-
naling can phosphorylate -DB1. Interestingly, the amount of 
the 75-kD -DB1 isoform was reduced in the DGC compared 
with the 89-kD isoform in erb2/4
/ myotubes. Whether this 
reduction is due to the prolonged absence of NRG signaling is 
not clear, but these results demonstrate clearly that the ab-
sence of NRG signaling through ErbB2/4 results in a dramatic 
reduction of phosphorylated -DB1 in the dystrophin–utrophin 
glycoprotein complex (DGC).
Unlike in cultured myotubes, phosphorylation of -DB1 
could not be detected when assayed in synaptic and in extrasyn-
aptic fragments of diaphragm from erbb2/4
/ and wild-type 
mice, respectively (not depicted). Possible explanations are that 
synaptic -DB1 was occluded by nonsynaptic -DB1 and that 
muscles did not tolerate pretreatment with phosphatase inhibi-
tor; indeed, -DB1 phosphorylation could so far be resolved 
in cultured myotubes only after treatment with phosphatase 
inhibitors (Nawrotzki et al., 1998; Grady et al., 2003), so the 
equivalent experiment could not be performed.
Next, we examined whether genetic deletion of ErbBs in 
myotubes is associated with impaired stability of AChR clusters, 
as it is at erbb2/4
/ endplates in vivo (Figs. 1 and 3). To this 
end,  myotubes  derived  from  erbb2/4
/  and  from  wild-type 
neonatal muscles were grown on laminin substrates focally   
impregnated with neural agrin (Jones et al., 1996). Clusters were 
stained with -BTX–Alexa 594 and cells were incubated for 6 h at 
37°C to allow turnover of labeled receptors. As shown in Fig. 7 d, 
the area of AChR clusters decreased more rapidly with time 
in erbb2/4
/ than in wild-type myotubes. This result indicates 
acceleration of AChR migration out of the cluster in erbb2/4
/ 
myotubes; as a consequence, cluster size appeared reduced more 
rapidly over time. Post-staining clusters with -BTX–Alexa 488 
after 6 h of culturing showed new AChRs (labeled green) pre-
vailing  at  the  cluster  periphery,  demonstrating  that  overall 
cluster size, i.e., including newly inserted AChRs, was main-
tained (Fig. 7 d). Resolving a differential effect on recycling 
AChRs  was  not  possible  because,  unlike  at  mature  NMJs, 
AChRs in myotubes do not recycle into clusters (Bruneau et al., 
2005b). These data combined with those in Fig. 6 show that 
abolishment of NRG/ErbB signaling by removal either of NRG1 
or of its receptors impaired receptor stability in agrin-induced 
AChR clusters.
Finally, we examined whether defective laminin expres-
sion at erbb2/4
/ synapses could account for the synaptic phe-
notype in the erbb mutant mice (Grady et al., 2000; Sunderland 
et al., 2000; Patton et al., 2001; Fukazawa et al., 2003). Immuno-
cytochemical staining for laminin 5, 2, and 1 showed   
no  difference  to  wild-type  synapses,  however  (not  depicted).   
Together, these data indicate that both pharmacological and 
genetic ablation of NRG/ErbB signaling results in a lack of 
phosphorylation of -DB1, and as a consequence destabilizes 
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the mammalian NMJ (Slater, 2008). Therefore, all the defects 
described above, in conjunction with a small overall reduction 
in AChR density (Escher et al., 2005), will impair the efficacy 
of synaptic impulse transmission. This is what we observe here 
(Fig. 5): The normal safety factor of neuromuscular transmis-
sion in rat soleus muscle is 3.5 (Wood and Slater, 1997).   
d-TC at 340 nM (as used here) lowers the amplitude of minia-
ture endplate currents in wild-type mice by two thirds (Pennefather 
and Quastel, 1981), thus lowering the safety factor to 1.2. 
Based on these observations, the safety factor in the soleus of 
erbb2/4
/ mice was lowered by the d-TC treatment to critical 
levels where the functional effects of structural damage begin to 
affect impulse transmission during repetitive stimulation. The 
lowered safety factor may become detrimental when combined 
with its lowering as the animal ages (Valdez et al., 2010).
Numerous  reports  implicate  NRG/ErbB  signaling  and 
components of the DGC in the development of normal brain 
function (Mei and Xiong, 2008; Waite et al., 2009). It is thus 
tempting to speculate that ErbB-dependent stabilization of re-
ceptors in synaptic membranes by phosphorylation of -DB1 
contributes to some of the processes involved in the functional 
maturation of the central nervous system.
Materials and methods
Animals
Erbb2/4
/ mice have been described previously (Escher et al., 2005). 
Unless noted otherwise, experiments were done on sternomastoid muscles 
from 8–12-wk-old mice. For surgery and in vivo staining, animals were 
anesthetized with ketamine (87 mg per kg body weight) and xylazine (13 mg 
per kg body weight). Postoperative analgesia was by four injections of 
buprenorphine at 12-h intervals. For acute experiments, tested agents were 
injected and bath applied to the sternomastoid muscle and replaced by 
freshly prepared agent solution every 60 min for 4 or 8 h. The viability of 
muscles exposed to drugs in vivo was ascertained from their contractions 
in response to nerve stimulation. Mice were sacrificed with CO2. Animal 
handling was approved by the Cantonal Veterinary Office of Basel-Stadt.
Chemicals, antibodies, fusion constructs, and cell lines
ErbB inhibitors AG 879 and AG 1478 (EMD) were used at 10 µM (in vivo) 
or 5 µM (in culture), dynasore (Sigma-Aldrich) at 160 µM, and NRG-1 
(R&D Systems) at 5 nM. AChRs were labeled with either -BTX–Alexa594 
(Invitrogen) or -BTX-biotin followed by streptavidin–Alexa 488, 594 or 
647 (10 µg/ml; Invitrogen) or anti-AChR antibody Mab35 (Developmental 
Studies Hybridoma Bank [DSHB], Iowa City, IA). Synaptic components 
were  stained  with  antibodies  against  -dystroglycan  (DSHB),  utrophin 
(DSHB), rapsyn (Thermo Fisher Scientific), -actin (JLA20; DSHB), laminin 
5 (a gift from L. Sorokin, University of Münster, Münster, Germany), 
laminin 1 (Millipore), and laminin 2 (Santa Cruz Biotechnology, Inc.). 
The  anti-MuSK  and  pan  anti-Nav  antibodies  were  kind  gifts  from     
M.  Rüegg  (University  of  Basel,  Basel,  Switzerland)  and  R.  Levinson   
(University of Colorado, Denver, CO). Secondary antibodies conjugated 
to Alexa 488 were purchased from Invitrogen; Transferrin (Tf)-Alexa 647 
or Tf-Alexa 488 from Sigma-Aldrich. Antibodies for biochemical experi-
ments are listed in the respective paragraph below. Fusion constructs for 
GFP–-DB1 and GFP–-DB1-P3 were gifts from J.R. Sanes (Harvard University, 
Cambridge, MA) and C. Mouslim (University of Michigan, Ann Arbor, MI), 
respectively. -db
/ myoblasts were kind gifts from B. Pawlikowski and 
M. Maimone (Upstate Medical University, State University of New York, 
Syracuse, NY).
In vitro measurements of muscle strength
Soleus muscles were dissected with the soleus/sciatic nerve attached and 
mounted in a muscle testing setup (Heidelberg Scientific Instruments). Be-
fore tension measurements began, muscles were left to equilibrate in Krebs 
Ringer’s solution maintained at 30°C and gassed with 95% O2/5% CO2, 
and their resting length was adjusted to produce maximal twitch contraction 
prevented by 30 min of pharmacological ErbB blockade (Fig. 7). 
Similar concentrations of blockers increased AChR migration 
within hours (Fig. S3). Considering that overall anchoring of 
AChRs in the synaptic membrane is stable, it is remarkable that 
phosphorylation of -DB1 and the resulting change in AChR 
stability are regulated by NRG/ErbB signaling on a time scale 
of minutes to hours.
How could the lack of NRG/ErbB signaling be linked to 
AChR instability? One possibility is that phosphorylation of 
-DB1 may stabilize the DGC. Interestingly, the association of 
utrophin with syntrophin was not affected by ErbB blockade, at 
least in the pharmacologically blocked myotubes. This is unlike 
the ablation of -syntrophin, which causes loss of utrophin and 
NOS from the synapse (Adams et al., 2000). Conspicuously, 
NRG/ErbB phosphorylated only the smaller of two -DB1 vari-
ants precipitated either with anti-syntrophin or with anti–-DB1 
antibodies (Fig. 7).
How could abolishment of NRG/ErbB signaling affect 
specifically the migration of recycled, as opposed to nonrecy-
cled (preexisting) AChRs and induce focal disappearance of 
AChRs  and  postsynaptic  apparatus  from  the  synaptic  mem-
brane? Even in wild-type muscle the removal of recycled is 
faster than that of nonrecycled AChRs (Bruneau et al., 2005a), 
suggesting  that  during  the  process  of  intracellular  cycling, 
AChRs are modified/altered in a way to loosen/destabilize their 
interaction with the postsynaptic scaffold. The present data sug-
gest that this interaction is further destabilized when -DB1 is 
not phosphorylated. The resulting decrease in AChR density 
could then lead to the disintegration of the postsynaptic appa-
ratus as we observed previously after focal dissipation of 
AChRs by laser illumination from clusters in cultured myo-
tubes (Bruneau et al., 2008). The focal loss of AChRs may result 
from the uneven distribution of the AChRs over the entire syn-
apse, with the rapid removal of recycled AChRs due to ErbB 
deficiency lowering AChR density locally to levels triggering 
local disassembly of the postsynaptic apparatus.
At the structural level, destabilization of the synaptic scaf-
fold is suggested by the reduction in the number of folds in 
erbb2/4
/ mice. Defects in, or the absence of, a number of 
scaffold proteins including rapsyn, utrophin, dystrobrevin, 
dystroglycans are all associated with a similar reduction of the 
number of synaptic folds (Deconinck et al., 1997a,b; Grady   
et al., 1997, 1999, 2000). In line with this, the regions of the 
NMJs in erbb2/4
/ mice where folds are reduced appear pref-
erentially where AChRs are lost. The proteins of the underlying 
scaffold are also reduced (Fig. 4) and appear with AChRs in 
perisynaptic puncta (Fig. S4). The focal loss of AChRs, the re-
duction of synaptic folds, and the loss of entire branches of sub-
synaptic AChR clusters may represent progressive stages of the 
same disassembly process of the synapse. The early formation 
of AChR cluster perforations in mutants (a process that in wild-
type muscle was observed only at aged synapses) suggests that 
NRG/ErbB signaling at the NMJs might prevent the premature 
aging of synapses.
A high density of AChRs and voltage-gated sodium chan-
nels, and the presence of synaptic folds, are all important for the 
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(sternomastoid muscle: 160 µM for 4 h, COS-1 cells: dynasore previously 
used on muscle for 15 min) surface Tf was removed with ice-cold acetic 
acid/NaCl (0.2 M/0.5 M, 4 min). Muscles were stained with -BTX–Alexa 
594 (1 µg/ml, 1 h) and Tf-containing vesicles were quantitatively assessed 
as described before for AChR puncta. In the case of cells quantitative 
fluorescence analysis was performed as described previously (Hardel   
et al., 2008).
Confocal imaging
NMJs were imaged with a confocal scanning laser microscope (model 
SPE; Leica) using a HCX Plan Apochromat 100x objective (NA 1.46) and 
a resolution of 1024 × 1024 pixels. Quantitative differences potentially 
due to changes in the light source or camera were excluded by imaging 
control and mutant muscles within the same session.
Quantitative analysis of perforations
The percentage of perforated synapses was determined by calculating the 
fraction of NMJs in age-matched wild-type and mutant sternomastoid mus-
cle that contained at least one “hole” or “perforation”, defined as a region 
within the synaptic AChR cluster lacking -BTX binding, but covered by 
nerve terminal.
Preparation of primary muscle cultures
Neonatal leg muscles from wild-type and mutant neonatal muscle were 
minced, dissociated with collagenase type IV and dispase type II, and cells 
were plated on a laminin substrate in DME containing 2 mM glutamine, 
20% FCS, and 1% antibiotic/antimycotic solution. After 2 d, they were re-
suspended in PBS by brief trypsinization, treated with rat monoclonal anti–
mouse 7-integrin antibody (a gift from R. Kremer, University of California, 
San Francisco, San Francisco, CA), and purified using (magnetic) Dyna-
beads coated with sheep anti–rat IgG and a Dynal-MPC-L magnetic parti-
cle concentrator (Blanco-Bose et al., 2001). C2C12, wild-type, or -db
/ 
myotubes were cultured on laminin-coated dishes focally impregnated with 
agrin. For the preparation of the focally impregnated dishes COS-1 cells, 
transfected  with  a  plasmid  coding  for  full-length  chicken  agrin,  were 
seeded at a density of 7–20 × 10
3 cells per 30 mm laminin-coated culture 
dish. After 48 h, cells were extracted for 1 h in 2% Triton X-100 in PBS, fol-
lowed by intensive washing (6–8x 1 h PBS) and myoblast seeding (Jones 
et al., 1996). Subsequent differentiation was in DME, 5% horse serum, 
and 1% antibiotic/antimycotic solution. For biochemical analysis of -DB1 
phosphorylation at agrin-induced AChR clusters, myoblasts were seeded 
on laminin substrates coated uniformly with recombinant agrin. Agrin was 
nickel-affinity column purified from supernatants of EBNA-HEK 293 cell cul-
tures that had been transfected with a His-tagged agrin construct contain-
ing  95  kD  of  the  C  terminus  and  the  25-kD  laminin-binding  domain 
NtAc95agrin (a gift from M.A. Rüegg, University of Basel, Basel, Switzerland) 
of the N terminus of chick agrin and selected for stable expression. For 
biochemistry, 6-well dishes were coated with 10 µg/ml laminin (Invitrogen) 
followed by coating with 0.5 µg/ml agrin solution (37°C, 2 h) before cell 
plating. It should be noted that throughout the present paper, agrin was 
applied attached to the culture substrate rather than in solution to mimic the 
in vivo situation.
Differences in AChR removal from agrin-induced AChR clusters were 
estimated from cultures in which agrin was deposited locally on laminin. 
Unlike the uniform coating with agrin described above, this method pro-
duces locally confined agrin patches which, when contacting myotubes, 
induced locally confined AChR clusters. To avoid differences in cluster size 
due to varying transfection efficiencies (see following paragraph), only 
clusters in myotubes grown on the same batch of COS-1 cell transfections 
were compared, and cluster size was expressed relative to control values.
Quantitative analysis of AChR cluster size
To determine AChR removal in culture, agrin-induced AChR clusters in pri-
mary myotubes were stained fluorescently and incubated for 6 h at 37°C 
(to allow removal of fluorescent receptors). When the removal rate was 
monitored in the absence of the ligand (NRG), cells were preincubated for 
12 h with -NRG1 antibody (Escher et al., 2005; to suppress endogenous 
NRG signaling), stained as before, and incubated for 6 h at 37°C in the 
presence of either recombinant NRG1 or -NRG1 antibody. Cells were 
imaged (20x objective, NA 0.7) in wide field, and cluster sizes after 6 h 
were determined by measuring the area of the remaining AChR fluores-
cence in ImageJ (National Institutes of Health).
In situ hybridization
Probes and experimental protocols were as described previously (Moore 
et al., 2001). In brief, cRNA probes used were derived from full-length 
in response to single stimuli applied once every 2 min. Muscles were 
stimulated either indirectly via the sciatic nerve through a suction electrode, 
or directly via a pair of extracellular electrodes placed in the bath on both 
sides of the muscle. Muscle force was digitized at 4 kHz by using an AD 
Instruments converter and stimulated with 15-V pulses for 0.5 ms. Soleus 
tetanus  was  recorded  in  response  to  1,100-ms  pulses  at  10–150  Hz   
(Delbono et al., 2007). After change of solutions, 30 min were allowed 
before tension measurements were resumed.
In vivo labeling, live animal imaging, and quantitative  
fluorescence measurements
To monitor AChR removal from the synapse, the sternomastoid muscle was 
labeled for 1 h with 5 µg/ml -BTX–Alexa594 (a dose that has previously 
been demonstrated to be sufficient to saturate all receptors [Bruneau et al., 
2005a]) and superficial synapses were imaged over 3 d.
To determine the removal rate of the different AChR pools (preexist-
ing and recycled AChRs), the sternomastoid muscle of anesthetized mice 
was exposed to -BTX-biotin (1 µg/ml, 10 min) followed by a single satu-
rating dose of streptavidin–Alexa 488, so that synaptic transmission re-
mained functional (Akaaboune et al., 2002). 5 d later, recycled receptors 
that had lost the streptavidin–Alexa 488 in the process of recycling   
(Bruneau et al., 2005a) and were reinserted into the synaptic membrane, 
were labeled with streptavidin–Alexa 594 . All controls for the specificity 
of the biotin–streptavidin dissociation have been worked out previously 
(Bruneau et al., 2005a). Doubly stained synapses (recycled [red] and pre-
existing [green] receptors) on the surface of the muscle were immediately 
imaged and reimaged 24 and 48 h later. The fluorescence intensity of la-
beled AChR at wild-type and erbb2/4
/ neuromuscular junctions was 
assayed using a quantitative fluorescence imaging technique, as described 
previously (Turney et al., 1996). This technique incorporates compensation 
for image variation that may be caused by spatial and temporal changes 
in the light source and camera between imaging sessions by calibrating 
the images with a nonfading reference standard. This technique involves 
repetitive imaging of the same fluorescent ligands. Thus, as long as we ver-
ified that labeling had reached saturation and that the image pixel intensity 
was not saturated, it was relatively trivial to get an accurate quantitative 
measurement of the relative number of AChRs. Image analysis was per-
formed  using  a  procedure  written  for  Matlab  (The  Mathworks),  which   
allows to approximate the background fluorescence by selecting a boundary 
region around the junction and subtracting it from the original image, and 
the mean and the total intensity was summed (Bruneau et al., 2005a;   
Martinez-Pena  y  Valenzuela  et  al.,  2005).  Total  fluorescence  intensity   
(a measure of the total number of AChRs) was expressed as 100% at the 
first view and normalized to this on each successive view.
To compare puncta number in erbb2/4
/ and control NMJs, pre-
existing AChRs were labeled with -BTX-biotin (3 µg/ml, 90 min), followed 
by strepatavidin–Alexa 647 (10 µg/ml, 3 h). 5 d later, recycled AChRs 
were visualized by streptavidin–Alexa 594 (10 µg/ml, 3 h) and another   
2 d later, surface AChRs were labeled by Mab35-antibody/Alexa 488 in 
nonpermeabilizing  conditions.  The  number  of  fluorescent  AChR  puncta 
was determined in the vicinity of the NMJs. When puncta were counted in 
the perisynaptic region up to 100 µm on both sides of the synapse, we ob-
served a significant drop in puncta number at 15–20 µm away from the 
synapse. Therefore, we reduced the area of interest to 25 µm from the syn-
apse in favor of higher magnification, which did not affect the relative dif-
ferences in puncta number in any of the conditions tested.
To study the effect of ErbB blockers and dynasore on the removal of 
AChR pools (recycled and preexisting AChRs), recycled AChRs of wild-
type sternomastoid muscle were stained as described above and were then 
bathed immediately with both AG 879 and AG 1478 (10 µM), dynasore 
(160 µM), or Ringer’s solution for 8 h. At the end of the experiment, surface 
AChRs were labeled with Mab35 without permeabilization. After fixation 
and mounting, superficial synapses were imaged confocally.
Immunocytochemistry
For immunostainings, muscles were fixed with PFA. Teased fiber bundles 
were blocked in PBS/20% normal goat serum (NGS)/ 1.5% Triton X-100 
(1 h, 4°C) and stained with primary antibody in PBS/2% bovine serum   
albumin (BSA)/0.5% Triton X-100 (overnight, 4°C). In the case of extracellu-
lar epitopes, antibody was added directly. Extensive washing was followed 
by incubation of the fibers with -BTX–Alexa 594 (1 µg/ml) and secondary 
antibody coupled to Alexa488 (45 min, room temperature).
Transferrin uptake was performed with Tf–Alexa 647 (15 µg/ml,   
10 min, COS-1 cells on ice) or Tf–Alexa 488 (40 µg/ml, 45 min, sterno-
mastoid muscle). After incubation in the absence or presence of dynasore 1183 NRG/ErbB function at the neuromuscular junction • Schmidt et al.
AChR puncta and streaks in wild-type NMJs treated with AG1478/AG879 
(ErbB kinase inhibitors). Figure S4 illustrates that rapsyn and utrophin 
co-migrate with AChRs to perisynaptic sites and that this co-migration is 
accelerated in erbb2/4
/ NMJs. Figure S5 displays the full blot of the 
anti-syntrophin IP from C2C12 myotubes treated with AG879 or AG1478 
compared with nontreated control. Blots were exposed to anti--DB1 and anti-
phosphotyrosine (4G10) antibodies. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201107083/DC1.
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cDNA encoding rat AChR-subunits or from cloned cDNA fragments encod-
ing the extracellular domain of rat MuSK (Met-1 to Ser-435). Synaptic 
AChR clusters were localized by staining with -BTX–Alexa 594 in 14-µm-
thick frozen sections and hybridized with 
35S-labeled cRNA. PFA (4%)-
fixed  sections  were  treated  with  proteinase  K  (20  µg/ml  in  50  mM 
TrisHCl/5 mM EDTA) for 8.5 min at room temperature, incubated for 10 min 
in 2.5% acetic anhydride in 0.1 M triethanolamine (pH 7.5), dehydrated 
through graded ethanol, and prehybridized for 3 h in hybridization buffer 
at 50°C. They were then hybridized overnight at 50°C with cRNA probes 
containing 
35S-labeled CTP and UTP (GE Healthcare) by using riboprobe 
concentrations between 40,000 and 180,000 cpm l
1. After washing 
with sodium-Tris-EDTA (NTE) buffer, sections were treated with 20 µg/ml 
RNase A for 45 min at 37°C and subsequently washed with increasing 
stringency (NTE and 2× sodium-sodium citrate [SSC] buffer at 37°C/0.1 × 
SSC at 50°C). After ethanol dehydration, they were dipped in Kodak NTB2 
emulsion and exposed for 5–7 wk at 4°C.
Electron microscopy
Mice were perfused with 2.5% glutaraldehyde in 0.1 M sodium phos-
phate, pH 7.4, and muscles were post-fixed overnight at 4°C. Muscle 
pieces containing endplate regions were treated with 1% OsO4 in 0.1 M 
cacodylate buffer, pH 7.2, rinsed in 1% Na2SO4 in 0.1 M cacodylate 
buffer, and embedded in Epon. Thin sections were post-stained with uranyl 
acetate and lead citrate, and were examined with an electron microscope 
(model EM400; Philips). The numbers of folds per µm of synaptic contact 
length was determined from prints.
Immunoaffinity purification and immunoblotting of protein complexes
To inhibit tyrosine phosphatases, peroxivanadate was prepared as de-
scribed previously (Nawrotzki et al., 1998). In brief, sodium peroxivana-
date was prepared fresh each time, just before use, by mixing 100 µl of 
100 mM sodium orthovanadate and 200 µl of 100 mM H2O2 and then by 
adding 9.7 ml of prewarmed (37°C) serum-free medium. Peroxivanadate, 
ErbB inhibitors AG879 and AG1478 (5 µM) as well as NRG1- (5 nM) 
were applied in serum-free DME (37°C, 30 min).
Myotubes from six wells were harvested in 300 µl of lysis buffer 
and protein complexes were purified as described previously (Kramarcy 
et al., 1994). In brief, myotubes harvested in ice-cold lysis buffer (10 mM 
Na3PO4, pH 7.8, 150 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1% Triton 
X-100, protease inhibitor mixture [Roche], and phosphatase inhibitors 
Pic1 and Pic2 [Sigma-Aldrich]) were homogenized in a Dounce homo-
genizer and incubated for 3 h at 4°C with protein G–coupled mouse mono-
clonal syntrophin antibody 1351 (a kind gift from S.C. Froehner and M. 
Adams, University of Washington, Seattle, WA) or rabbit anti–-dystrobrevin 
antibody (a kind gift of D.J. Blake and R. Nawrotzki, University of Cardiff, 
Wales, UK). Beads were then washed in lysis buffer containing prote-
ase inhibitors but without Triton X-100, resuspended in SDS loading buf-
fer, and denatured (94°C, 3 min) before loading on either an 8–15%   
gradient  or  8%  acrylamide/0.8%  bis-acrylamide  gels  buffered  with 
Tris-glycine.
Gels were transferred onto PVDF membranes (Millipore) and subject 
to ECL (Thermo Fisher Scientific) development after incubation with primary 
and secondary antibodies. Milk (3%) was used as a blocking reagent 
except for the anti-phosphotyrosine 4G10 antibody, for which 3% BSA 
was used. The following primary antibodies were used: mouse monoclonal 
anti-syntrophin 1351 culture supernatant (30 µl/6 wells of myotubes), rab-
bit anti- syntrophin 259 (5 µg/ml for Westerns; a kind gift of Stanly   
C. Froehner), rabbit anti--dystrobrevin (1:1,000; a kind gift from Derek J. 
Blake), mouse anti-phosphotyrosine, clone 4G10 (Milipore), and mouse 
anti-utrophin  monoclonal  (1:300).  Goat  anti–mouse  IgG-HRP  and  goat 
anti–rabbit  IgG-HRP  secondary  antibodies  (Santa  Cruz  Biotechnology, 
Inc.) were used at a 1:5,000 dilution.
Statistical analyses
Data are given as mean ± SEM. Quantitative comparisons of numerical 
datasets were tested for statistical significance by means of the nonpara-
metric, two-sided U test (Mann & Whitney) with *, P < 0.05; **, P < 0.01; 
and ***, P > 0.001 unless stated otherwise. In the case of categorical da-
tasets, 
2 statistics were performed.
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